Metraipolis › archive › dc_b9822b6bbc00
TLR4: A Potential Therapeutic Target in the Experimental Pathogenesis of Hemolytic-Uremic Syndrome — Europe PMC PMID:42794422
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/42794422
- DOI
- 10.3390/ijms27187992
- License (as archived)
- solo-consultazione
- Archived
- 2026-10-16T00:09:51.632Z
- SHA-256 of the archived text
be618d2e8c44873a6280da05b63eed3eca7af43a73667ce67b5f086d49b5b68d- Stable URL of this page
https://metraipolis.com/documento/dc_b9822b6bbc00
How to cite
TLR4: A Potential Therapeutic Target in the Experimental Pathogenesis of Hemolytic-Uremic Syndrome — Europe PMC PMID:42794422 — Europe PMC (en), https://europepmc.org/article/MED/42794422 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b9822b6bbc00 (Metraipolis archive dc_b9822b6bbc00, sha256 be618d2e8c44873a6280da05b63eed3eca7af43a73667ce67b5f086d49b5b68d)
BibTeX
@misc{dcb9822b6bbc00,
title = {TLR4: A Potential Therapeutic Target in the Experimental Pathogenesis of Hemolytic-Uremic Syndrome — Europe PMC PMID:42794422},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/42794422},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b9822b6bbc00; sha256 be618d2e8c44873a6280da05b63eed3eca7af43a73667ce67b5f086d49b5b68d},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42794422. Agents can read the archived copy with the MCP tool read_document.